$2.06
−1.26%Oct 28, 2026, 07:11 UTC
DataMeds AI, Inc. signed a letter of intent to acquire QLPM intellectual property assets from EOS Technology Holdings and Scilex Holding Co, acquire a controlling interest in HealthBridge Advisors, LLC and Tollo Health, Inc. through an exchange of membership interests, and enter related licensing and services arrangements, with consideration in DataMeds common shares.
Oct 2, 2026, 12:05 UTC
SCIENTURE announced that its Arbli product has been added to the formularies at three leading U.S. pediatric academic medical centers and hospitals.
Source:Sep 29, 2026, 20:30 UTC
Scilex Holding Co amended a promissory note with Vivasor, Inc., increasing the maximum credit amount under its uncommitted revolving line of credit from $20,000,000 to $30,000,000.
Sep 22, 2026, 12:15 UTC
SCIENTURE entered an agreement with a distribution partner to expand commercial reach of REZENOPY across approximately 2,000 opioid treatment program clinics and other addiction treatment center networks in the United States.
Source:Aug 17, 2026, 13:00 UTC
DataMeds AI announced the pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate intellectual properties and deliver the 'Health Lives Here' consumer app in partnership with NFL Alumni Health.
Source:Jun 25, 2026, 15:35 UTC
Scilex loan was substantially repaid to Oramed Pharmaceuticals.
Source:Jun 16, 2026, 11:52 UTC
Scilex Holding Company announced that its Dream Bowl I Meme Coin tokens will list on Biconomy Exchange as early as June 23, 2026.
Source:Jun 4, 2026, 13:00 UTC
Scilex Holding Company set June 15, 2026 as the payment date for its previously announced dividend of Semnur Pharmaceuticals common stock to holders of Scilex common stock and other eligible equity securities.